The economic burden of cervical cancer in Eswatini: Societal perspective.

<h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer...

Full description

Bibliographic Details
Main Authors: Cebisile Ngcamphalala, Ellinor Östensson, Themba G Ginindza
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0250113
_version_ 1818825177140559872
author Cebisile Ngcamphalala
Ellinor Östensson
Themba G Ginindza
author_facet Cebisile Ngcamphalala
Ellinor Östensson
Themba G Ginindza
author_sort Cebisile Ngcamphalala
collection DOAJ
description <h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini.<h4>Materials and methods</h4>The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality.<h4>Results</h4>The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million).<h4>Conclusion</h4>The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer.
first_indexed 2024-12-19T00:07:37Z
format Article
id doaj.art-780611c77d0f494ab2e46df2013dcf60
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T00:07:37Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-780611c77d0f494ab2e46df2013dcf602022-12-21T20:46:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e025011310.1371/journal.pone.0250113The economic burden of cervical cancer in Eswatini: Societal perspective.Cebisile NgcamphalalaEllinor ÖstenssonThemba G Ginindza<h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini.<h4>Materials and methods</h4>The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality.<h4>Results</h4>The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million).<h4>Conclusion</h4>The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer.https://doi.org/10.1371/journal.pone.0250113
spellingShingle Cebisile Ngcamphalala
Ellinor Östensson
Themba G Ginindza
The economic burden of cervical cancer in Eswatini: Societal perspective.
PLoS ONE
title The economic burden of cervical cancer in Eswatini: Societal perspective.
title_full The economic burden of cervical cancer in Eswatini: Societal perspective.
title_fullStr The economic burden of cervical cancer in Eswatini: Societal perspective.
title_full_unstemmed The economic burden of cervical cancer in Eswatini: Societal perspective.
title_short The economic burden of cervical cancer in Eswatini: Societal perspective.
title_sort economic burden of cervical cancer in eswatini societal perspective
url https://doi.org/10.1371/journal.pone.0250113
work_keys_str_mv AT cebisilengcamphalala theeconomicburdenofcervicalcancerineswatinisocietalperspective
AT ellinorostensson theeconomicburdenofcervicalcancerineswatinisocietalperspective
AT thembagginindza theeconomicburdenofcervicalcancerineswatinisocietalperspective
AT cebisilengcamphalala economicburdenofcervicalcancerineswatinisocietalperspective
AT ellinorostensson economicburdenofcervicalcancerineswatinisocietalperspective
AT thembagginindza economicburdenofcervicalcancerineswatinisocietalperspective